Rex C. Haydon to Tumor Cells, Cultured
This is a "connection" page, showing publications Rex C. Haydon has written about Tumor Cells, Cultured.
Connection Strength
0.130
-
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res. 2002 May; 8(5):1288-94.
Score: 0.046
-
Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling. Int J Oncol. 2011 Feb; 38(2):437-45.
Score: 0.021
-
Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett. 2005 Nov 08; 229(1):135-48.
Score: 0.015
-
Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 2003 Aug; 85(8):1544-52.
Score: 0.013
-
Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett. 2003 Apr 25; 193(2):161-70.
Score: 0.012
-
Fluorescence-based functional assay for Wnt/beta-catenin signaling activity. Biotechniques. 2002 Nov; 33(5):1126-8, 1130, 1132 passim.
Score: 0.012
-
Tetracycline-regulated gene expression mediated by a novel chimeric repressor that recruits histone deacetylases in mammalian cells. J Biol Chem. 2001 Nov 30; 276(48):45168-74.
Score: 0.011